“Europe Faces Threat as Syria and Lebanon Ramp Up Captagon Drug Production”

Europe Faces Potential Influx of Captagon Drug Amidst Political Shifts in the Middle East

Europe prepares for a potential influx of Captagon drug from the Middle East due to political shifts and Gulf crackdowns. Captagon, produced and trafficked by groups linked to Syrian President Assad and Hezbollah, is popular in the Middle East for its energy-boosting effects. The drug trade, estimated at $10 billion over three years, is expanding, raising concerns about increased flow into Europe. Recent Saudi crackdowns prompt producers to seek new markets, raising alarm among policymakers. Despite denials, Captagon trade may become a threat, affecting Europe’s security. Authorities worry about the adaptation of traffickers and potential spillover into local markets. US, EU, and UK impose sanctions on individuals linked to Captagon trade. The drug’s popularity and trade have escalated, posing concerns for societies and international relations.